Platinum-free Interval May Predict Duration of Maintenance Bevacizumab and Survival in Platinum-sensitive Recurrent Ovarian Cancer
SH Oh, SJ Park, S Lee, S Lee, HS Kim - in vivo, 2024 - iv.iiarjournals.org
Background/Aim: We investigated factors affecting the long-term duration of bevacizumab-
based maintenance therapy (BMT) and survival in patients with the first platinum-sensitive …
based maintenance therapy (BMT) and survival in patients with the first platinum-sensitive …